From June 13 through June 16, 2026, the Endocrine Society is hosting its annual conference, ENDO2026, in Chicago, Illinois. ENDO2026 brings together thousands of attendees from across the globe for three days of dynamic, thought-provoking sessions and discussions on the latest in hormone health and science.
Today’s preview highlights currently scheduled sessions on topics focusing on and related to thyroid cancer. Dates and times are current as of Tuesday, May 5, 2026. No thyroid cancer sessions are scheduled for Sunday, June 14. Descriptions have been edited for clarity and brevity. For the most up-to-date schedule information, refer to the conference’s official schedule.
Saturday, June 13
- Recent Advances in the Management of Anaplastic Thyroid Cancer
- 9:45 AM – 10:25 AM
- Description: This session covers the baseline testing and treatment of anaplastic thyroid cancer, optimal management approaches for BRAF V600E–variant ATC and current management strategies for non–BRAF V600E–variant ATC.
- Dissecting the Role of RET in Thyroid Cancer
- 10:45 AM – 12:15 PM
- Description: This sessions features multiple discussions on topics including neoadjuvant approached in differentiated thyroid cancer, RET-fusions in differentiated thyroid cancer, and more.
Monday, June 15
- Targeted Therapy in Advanced Thyroid Cancer
- 2:35 PM – 3:15 PM
- Description: This session covers the role of driver molecular alterations in advanced differentiated thyroid cancers and the importance of identifying them to guide optimal systemic treatment decisions. It also explores how genotype-phenotype correlations link molecular alterations to histologic subtypes, offering insight into varied disease behavior and opportunities to optimize treatment.
- Key Evaluation of Thyroid Nodules
- 4:30 PM – 6:00 PM
- Description: This session features multiple discussions, one of note is Ablative Strategies for Thyroid Nodules or Locoregional Control of Thyroid Cancer.
Tuesday, June 16
- Immuno-Metabolism in Endocrine Neoplasia: From Pathophysiology to Therapeutics
- 9:00 AM – 10:30 AM
- Description: This session features multiple discussion, one of note is Immune-metabolic Deregulation in Thyroid Carcinoma.
- Pediatric Thyroid Cancer
- 10:45 AM – 12:15 PM
- Description: This session features discussions on multiple topics including the evolving molecular and genetic landscape of pediatric thyroid cancer, the evolving treatment of pediatric papillary thyroid carcinoma, and more.
Sign up for alerts and stay informed on the latest clinical guidelines and guideline updates.